Quick Answer
ACTUATE THERAPEUTICS, INC. reported Operating Income of -$22.50 million for fiscal year 2025.
ACTUATE THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$22.50M | +10.6% |
| 2024 | -$25.16M | -0.7% |
| 2023 | -$24.97M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.47M | -1.5% | +8.3% |
| June 30, 2025 | -$5.97M | -9.8% | +6.2% |
| March 31, 2025 | -$6.37M | +18.1% | -18.0% |
| September 30, 2024 | -$5.39M | +16.7% | +0.8% |
| June 30, 2024 | -$5.44M | +2.7% | +30.1% |
| March 31, 2024 | -$7.77M | — | -20.0% |
| September 30, 2023 | -$6.48M | — | -16.0% |
| June 30, 2023 | -$5.58M | — | — |
- ACTUATE THERAPEUTICS, INC. showed an increase of +10.6% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, ACTUATE THERAPEUTICS, INC.’s operating income has grown by 9.9% (from -$24.97 million to -$22.50 million).
- The most recent figure is from ACTUATE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: